Dr. Reddy’s layoffs | Pharma Major cuts labour costs by 25%, and employees with packages of over Rs 1 crore to exit: Report

Dr. Reddy’s layoffs: Pharmaceutical Master Dr. Reddy’s lab may reduce its labor costs by nearly 25% when starting a major program. Several senior executives have been asked to resign, including many profitable employees, according to the Business Standards Report. ₹10 million per year.

The report also added that employees of the 50-55-year age group working in the pharmaceutical manufacturer’s research and development (R&D) department have been offered voluntary retirement. The report said several senior individuals in various departments had been asked to resign.

Dr. Reddy’s lab announces after-tax consolidated profits increase by 2% year-on-year (PAT) ₹For the quarter ended December 2024 (third quarter), the quarter was 14133 million. The third quarter of last year’s Paipai Station ₹13.789 million.

The revenue from operating in the quarter comes from ₹83,586 million, record 16% year-on-year jump ₹72.148 million copies were released in the December 2023 quarter.

The company said the growth was driven primarily by recently acquired revenue from nicotine replacement therapy (NRT) portfolio, India and emerging markets.

Global revenue in generic drug sector increased by 17% in the third quarter, while revenue in the pharmaceutical services and positive ingredients (API) sector increased by 5%.

Revenue before interest, taxes, depreciation and amortization in the third quarter ₹22.982 million ₹21.17 million in the same period last year, ₹22.803 million fiscal year 2.5 million